Search research articles
Contact Us
Filters
Showing results (101-110 of 119) with videos related to
Page
of 12
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
September 12, 2020
An unusual presentation of recurrent T cell lymphoma: angiocentric pattern of cutaneous uptake on [<sup>18</sup>F]FDG PET/CT
Kip E Guja, Ryanne Brown, Brad Girod, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 20, 2019
Prospective Evaluation of <sup>18</sup>F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer in an Academic Center: A Focus on Disease Localization and Changes in Management
Hong Song, Caitlyn Harrison, Heying Duan, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
June 1, 2023
Predicting FDG-PET Images From Multi-Contrast MRI Using Deep Learning in Patients With Brain Neoplasms
Jiahong Ouyang, Kevin T Chen, Rui Duarte Armindo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 6, 2021
Prognostic Value of Bone Marrow Metabolism on Pretreatment <sup>18</sup>F-FDG PET/CT in Patients with Metastatic Melanoma Treated with Anti-PD-1 Therapy
Ryusuke Nakamoto, Lisa C Zaba, Tie Liang, et al.
Molecular Imaging and Biology
|
January 20, 2021
The Clinical Utility of <sup>18</sup>F-Fluciclovine PET/CT in Biochemically Recurrent Prostate Cancer: an Academic Center Experience Post FDA Approval
Ryusuke Nakamoto, Caitlyn Harrison, Hong Song, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 17, 2022
A Pilot Study of <sup>68</sup>Ga-PSMA11 and <sup>68</sup>Ga-RM2 PET/MRI for Biopsy Guidance in Patients with Suspected Prostate Cancer
Heying Duan, Pejman Ghanouni, Bruce Daniel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 5, 2022
<sup>68</sup>Ga-PSMA-11 PET/MRI in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Adenocarcinoma: PET Findings Correlate with Outcomes After Definitive Treatment
Farshad Moradi, Heying Duan, Hong Song, et al.
The Lancet. Oncology
|
February 29, 2024
<sup>68</sup>Ga-RM2 PET-MRI versus MRI alone for evaluation of patients with biochemical recurrence of prostate cancer: a single-centre, single-arm, phase 2/3 imaging trial
Heying Duan, Farshad Moradi, Guido A Davidzon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 6, 2021
PSMA- and GRPR-Targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer
Lucia Baratto, Hong Song, Heying Duan, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 17, 2020
Prognostic value of volumetric PET parameters at early response evaluation in melanoma patients treated with immunotherapy
Ryusuke Nakamoto, Lisa C Zaba, Jarrett Rosenberg, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 119) with videos related to
Sort By:
Page
of 12
European Journal of Nuclear Medicine and Molecular Imaging
|
September 12, 2020
An unusual presentation of recurrent T cell lymphoma: angiocentric pattern of cutaneous uptake on [<sup>18</sup>F]FDG PET/CT
Kip E Guja, Ryanne Brown, Brad Girod, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 20, 2019
Prospective Evaluation of <sup>18</sup>F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer in an Academic Center: A Focus on Disease Localization and Changes in Management
Hong Song, Caitlyn Harrison, Heying Duan, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
June 1, 2023
Predicting FDG-PET Images From Multi-Contrast MRI Using Deep Learning in Patients With Brain Neoplasms
Jiahong Ouyang, Kevin T Chen, Rui Duarte Armindo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 6, 2021
Prognostic Value of Bone Marrow Metabolism on Pretreatment <sup>18</sup>F-FDG PET/CT in Patients with Metastatic Melanoma Treated with Anti-PD-1 Therapy
Ryusuke Nakamoto, Lisa C Zaba, Tie Liang, et al.
Molecular Imaging and Biology
|
January 20, 2021
The Clinical Utility of <sup>18</sup>F-Fluciclovine PET/CT in Biochemically Recurrent Prostate Cancer: an Academic Center Experience Post FDA Approval
Ryusuke Nakamoto, Caitlyn Harrison, Hong Song, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 17, 2022
A Pilot Study of <sup>68</sup>Ga-PSMA11 and <sup>68</sup>Ga-RM2 PET/MRI for Biopsy Guidance in Patients with Suspected Prostate Cancer
Heying Duan, Pejman Ghanouni, Bruce Daniel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 5, 2022
<sup>68</sup>Ga-PSMA-11 PET/MRI in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Adenocarcinoma: PET Findings Correlate with Outcomes After Definitive Treatment
Farshad Moradi, Heying Duan, Hong Song, et al.
The Lancet. Oncology
|
February 29, 2024
<sup>68</sup>Ga-RM2 PET-MRI versus MRI alone for evaluation of patients with biochemical recurrence of prostate cancer: a single-centre, single-arm, phase 2/3 imaging trial
Heying Duan, Farshad Moradi, Guido A Davidzon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 6, 2021
PSMA- and GRPR-Targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer
Lucia Baratto, Hong Song, Heying Duan, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 17, 2020
Prognostic value of volumetric PET parameters at early response evaluation in melanoma patients treated with immunotherapy
Ryusuke Nakamoto, Lisa C Zaba, Jarrett Rosenberg, et al.
Page
of 12